TechnologyAustralian biotech firm PolyActiva raises $26.4m series C Sridhar PJune 2, 2025June 2, 202501 mins Founded in 2010, PolyActiva has developed a biodegradable implant for glaucoma treatment. Post navigation Previous: F1 news: Max Verstappen one penalty point away from suspension after clash with George RussellNext: Polish conservative Nawrocki leads presidential vote Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
New York sues Valve, alleging its loot boxes are ‘quintessential gambling’ February 26, 2026February 26, 2026